(lp0
S'Analyst Calls for Exponential Upside for Idera Pharmaceuticals Yahoo Finance - Mar 25, 2017 Idera Pharmaceuticals Inc.  is focused on cancer and rare diseases, and it could be a what traders refer to as a three-bagger or four-bagger, if two analysts who made key calls in recent days end up being correct here.Idera Pharma Shares Could Be A Four-Bagger, JMP Says - Benzinga'
p1
aS'Idera Pharmaceuticals Advances Investigational Treatment  Intratumoral IMO ... Yahoo Finance - Apr 11, 2017 CAMBRIDGE, Mass. and EXTON, Pa., April 11, 2017  -- Idera Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, today&nbsp;...Idera Pharma  Advances Intratumoral IMO-2125 in Combination with ... - StreetInsider.com'
p2
aS"Wedbush Reiterates Outperform Rating for Idera Pharmaceuticals Inc  The Cerbat Gem - 19 hours ago Idera Pharmaceuticals Inc logo Wedbush restated their outperform rating on shares of Idera Pharmaceuticals Inc  in a research report released on Tuesday morning.17 hedge funds sold their entire positions in Idera Pharmaceuticals, Inc.  - Post AnalystRecent Update on Price Movements: Idera Pharmaceuticals, Inc.'s  - Is stories"
p3
aS'Idera Pharmaceuticals Presents Clinical Translational and Pre-Clinical Data ... Yahoo Finance - Apr 5, 2017 WASHINGTON, April 05, 2017  -- Idera Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, today is reporting additional&nbsp;...'
p4
aS"Idera Pharmaceuticals and XOMA Find Paths to Financial Growth Yahoo Finance - Mar 23, 2017 At Wednesday's close, XOMA Corporation found its stock scoot up $0.70 per share on Wednesday, to close at $6.045. The 13 percent increase was fueled by news that the company had fully prepaid its capital debt to Hercules Technology Growth, and it will&nbsp;..."
p5
aS'Two stocks can be a game changer in the market: Idera Pharmaceuticals, Inc ... The USA Commerce - 23 hours ago On the close of 04/13/2017 Idera Pharmaceuticals, Inc.  jumped 1.35% to hit $2.25. During the session shares stayed in the range from $2.30 to $2.21.'
p6
aS"Analysts Opinion Summary on: Idera Pharmaceuticals, Inc.  StandardOracle - Apr 12, 2017 Idera Pharmaceuticals, Inc.  added 1.82% to reach $2.24 in the previous trading session. Overall, 1.34 Million shares exchanged hands versus its average trading volume of 1.53 Million shares.Idera Pharmaceuticals  Stock: Gains On Clinical Advancement - CNA Finance Idera Pharmaceuticals, Inc.'s  stock price is Worth at $2.22 while ends ... - Hot Stocks Point"
p7
aS'Idera Pharmaceuticals Inc Risk Points versus Health Care CML News - Apr 7, 2017 This is a scatter plot analysis of the critical risk points from the option market for Idera Pharmaceuticals Inc  compared to its own past and the Health Care ETF.'
p8
aS'The Technical Charts For Idera Pharmaceuticals, Inc.  Say It All Today NY Stock News - Mar 28, 2017 The technicals for Idera Pharmaceuticals, Inc.  have taken shape, and with them a comprehensive picture has emerged.'
p9
aS'Trading Sheet: Watching the Numbers for Idera Pharmaceuticals, Inc.  Searcy News - 10 hours ago Tracking shares of Idera Pharmaceuticals, Inc. , the company has a current EV  of 226447.'
p10
a.